Terms: = Germ cell tumor AND PRDM16, KIAA1675, 63976, ENSG00000142611, MEL1, PFM13, Q9HAZ2
22 results:
1. Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors.
Wang L; Wei C; Wang Y; Huang N; Zhang T; Dai Y; Xue L; Lin S; Wu ZB
Front Endocrinol (Lausanne); 2023; 14():1149997. PubMed ID: 37534217
[TBL] [Abstract] [Full Text] [Related]
2. Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.
Biteghe FAN; Padayachee E; Davids LM; Chalomie NET; Ndong JC; Barth S
J Photochem Photobiol B; 2020 Oct; 211():111982. PubMed ID: 32866820
[TBL] [Abstract] [Full Text] [Related]
3. miR-410-3p is induced by vemurafenib via ER stress and contributes to resistance to BRAF inhibitor in melanoma.
Grzywa TM; Klicka K; Paskal W; Dudkiewicz J; Wejman J; Pyzlak M; Włodarski PK
PLoS One; 2020; 15(6):e0234707. PubMed ID: 32555626
[TBL] [Abstract] [Full Text] [Related]
4. Human melanoma brain metastases cell line MUG-mel1, isolated clones and their detailed characterization.
Heitzer E; Groenewoud A; Meditz K; Lohberger B; Liegl-Atzwanger B; Prokesch A; Kashofer K; Behrens D; Haybaeck J; Kolb-Lenz D; Koefeler H; Riedl S; Schaider H; Fischer C; Snaar-Jagalska BE; de'Jong D; Szuhai K; Zweytick D; Rinner B
Sci Rep; 2019 Mar; 9(1):4096. PubMed ID: 30858407
[TBL] [Abstract] [Full Text] [Related]
5. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract] [Full Text] [Related]
6. miR-101 reverses hypomethylation of the prdm16 promoter to disrupt mitochondrial function in astrocytoma cells.
Lei Q; Liu X; Fu H; Sun Y; Wang L; Xu G; Wang W; Yu Z; Liu C; Li P; Feng J; Li G; Wu M
Oncotarget; 2016 Jan; 7(4):5007-22. PubMed ID: 26701852
[TBL] [Abstract] [Full Text] [Related]
7. Activation of classical brown adipocytes in the adult human perirenal depot is highly correlated with prdm16-EHMT1 complex expression.
Nagano G; Ohno H; Oki K; Kobuke K; Shiwa T; Yoneda M; Kohno N
PLoS One; 2015; 10(3):e0122584. PubMed ID: 25812118
[TBL] [Abstract] [Full Text] [Related]
8. St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.
Kleemann B; Loos B; Scriba TJ; Lang D; Davids LM
PLoS One; 2014; 9(7):e103762. PubMed ID: 25076130
[TBL] [Abstract] [Full Text] [Related]
9. White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma.
Frontini A; Vitali A; Perugini J; Murano I; Romiti C; Ricquier D; Guerrieri M; Cinti S
Biochim Biophys Acta; 2013 May; 1831(5):950-9. PubMed ID: 23454374
[TBL] [Abstract] [Full Text] [Related]
10. Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death.
Sharma KV; Davids LM
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):156-63. PubMed ID: 22594986
[TBL] [Abstract] [Full Text] [Related]
11. Extended survival of glioblastoma patients after chemoprotective HSC gene therapy.
Adair JE; Beard BC; Trobridge GD; Neff T; Rockhill JK; Silbergeld DL; Mrugala MM; Kiem HP
Sci Transl Med; 2012 May; 4(133):133ra57. PubMed ID: 22572881
[TBL] [Abstract] [Full Text] [Related]
12. Photodynamic therapy-induced killing is enhanced in depigmented metastatic melanoma cells.
Sharma KV; Bowers N; Davids LM
Cell Biol Int; 2011 Sep; 35(9):939-44. PubMed ID: 21542806
[TBL] [Abstract] [Full Text] [Related]
13. KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro.
Carlie G; Ntusi NB; Hulley PA; Kidson SH
Br J Dermatol; 2003 Oct; 149(4):707-17. PubMed ID: 14616361
[TBL] [Abstract] [Full Text] [Related]
14. Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma.
Farkas B; Hantschel M; Magyarlaki M; Becker B; Scherer K; Landthaler M; Pfister K; Gehrmann M; Gross C; Mackensen A; Multhoff G
Melanoma Res; 2003 Apr; 13(2):147-52. PubMed ID: 12690297
[TBL] [Abstract] [Full Text] [Related]
15. Biotransformation of the antimelanoma agent betulinic acid by Bacillus megaterium ATCC 13368.
Chatterjee P; Kouzi SA; Pezzuto JM; Hamann MT
Appl Environ Microbiol; 2000 Sep; 66(9):3850-5. PubMed ID: 10966400
[TBL] [Abstract] [Full Text] [Related]
16. Informatic selection of a neural crest-melanocyte cDNA set for microarray analysis.
Loftus SK; Chen Y; Gooden G; Ryan JF; Birznieks G; Hilliard M; Baxevanis AD; Bittner M; Meltzer P; Trent J; Pavan W
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9277-80. PubMed ID: 10430933
[TBL] [Abstract] [Full Text] [Related]
17. The expression of C-myb in human metastatic melanoma cell lines and specimens.
Walker MJ; Silliman E; Dayton MA; Lang JC
Anticancer Res; 1998; 18(2A):1129-35. PubMed ID: 9615777
[TBL] [Abstract] [Full Text] [Related]
18. cell-cell adherence as a selection method for the generation of anti-melanoma monoclonal antibodies.
Barral AM; Fernández A; Faxas ME; Pérez X; García CA; Rosén A
J Immunol Methods; 1997 Apr; 203(1):103-9. PubMed ID: 9134034
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemical demonstration of S-100 protein and melanoma-associated antigens in melanocytic nevi.
Paul E; Cochran AJ; Wen DR
J Cutan Pathol; 1988 Jun; 15(3):161-5. PubMed ID: 2456315
[TBL] [Abstract] [Full Text] [Related]
20. Immunohistochemical reactivity of the antimelanoma monoclonal antibody MEL-1.
Clemente C
Tumori; 1985 Jun; 71(3):225-32. PubMed ID: 3895683
[TBL] [Abstract] [Full Text] [Related]
[Next]
